摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

9-methoxy-2-(pyridin-4-yl)-5,6-dihydro-4H-1,3-diazabenzo[e]azulen-1-ol | 477977-46-1

中文名称
——
中文别名
——
英文名称
9-methoxy-2-(pyridin-4-yl)-5,6-dihydro-4H-1,3-diazabenzo[e]azulen-1-ol
英文别名
3-Hydroxy-13-methoxy-4-pyridin-4-yl-3,5-diazatricyclo[8.4.0.02,6]tetradeca-1(10),2(6),4,11,13-pentaene
9-methoxy-2-(pyridin-4-yl)-5,6-dihydro-4H-1,3-diazabenzo[e]azulen-1-ol化学式
CAS
477977-46-1
化学式
C18H17N3O2
mdl
——
分子量
307.352
InChiKey
IUZAWGYAQVNELI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    23
  • 可旋转键数:
    2
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    60.2
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    9-methoxy-2-(pyridin-4-yl)-5,6-dihydro-4H-1,3-diazabenzo[e]azulen-1-ol 在 palladium 10% on activated carbon 三氯化磷甲酸铵 作用下, 以 DMF (N,N-dimethyl-formamide) 为溶剂, 反应 4.0h, 生成 13-methoxy-4-pyridin-4-yl-3,5-diazatricyclo[8.4.0.02,6]tetradeca-1(10),2(6),3,11,13-pentaene
    参考文献:
    名称:
    EP1403256
    摘要:
    公开号:
  • 作为产物:
    参考文献:
    名称:
    Novel potent antagonists of human neuropeptide Y-Y5 receptor. Part 4: tetrahydrodiazabenzazulene derivatives
    摘要:
    Novel tetrahydrodiazabenzazulene derivatives. designed from the lead compound 1 discovered by screening of our in-house chemical library, were prepared and found to be potent neuropeptide Y-Y5 (NPY-Y5) receptor antagonists. The structure-activity relationships are described. Compounds 7 (FR240662) and 16 (FR252384) were especially attractive owing to their high affinities for the NPY-Y5 receptors, oral absorption and permeability to brain. (C), 2002 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(02)00090-2
点击查看最新优质反应信息

文献信息

  • Fused imidazole derivative
    申请人:——
    公开号:US20040198791A1
    公开(公告)日:2004-10-07
    According to the present invention, fused imidazole derivatives of the general formula: 1 wherein R 1 is a hydrogen atom, a halogen atom, hydroxy group, a lower alkyl group or a lower alkoxy group, R 2 is an aryl group, benzodioxanyl group, or 5-6 membered, monocyclic, unsaturated, heterocyclic group containing nitrogen atom(s) which may be substituted with lower alkyl, trityl or oxo, R 3 is a hydrogen atom or hydroxy group, A is a group represented by the formula: —(CH 2 ) m — or —O—(CH 2 ) m — [wherein m is an integer of 1-3] and their salts are provided.
    根据本发明,提供了一般式为:1的熔融咪唑衍生物,其中R1为氢原子、卤素原子、羟基、低碳基或低氧基;R2为芳基、苯二氧基基团或含有氮原子的5-6成员单环不饱和杂环基团,可被低碳基、三苯基或氧代取代;R3为氢原子或羟基;A为以下式子所代表的基团:—(CH2)m—或—O—(CH2)m—[其中,m为1-3的整数]及其盐。
  • EP1403256
    申请人:——
    公开号:——
    公开(公告)日:——
  • Novel potent antagonists of human neuropeptide Y-Y5 receptor. Part 4: tetrahydrodiazabenzazulene derivatives
    作者:Yoshinari Satoh、Chie Hatori、Harunobu Ito
    DOI:10.1016/s0960-894x(02)00090-2
    日期:2002.4
    Novel tetrahydrodiazabenzazulene derivatives. designed from the lead compound 1 discovered by screening of our in-house chemical library, were prepared and found to be potent neuropeptide Y-Y5 (NPY-Y5) receptor antagonists. The structure-activity relationships are described. Compounds 7 (FR240662) and 16 (FR252384) were especially attractive owing to their high affinities for the NPY-Y5 receptors, oral absorption and permeability to brain. (C), 2002 Elsevier Science Ltd. All rights reserved.
查看更多